Moderna’s COVID-19 vaccine was 100% effective in adolescents aged 12 to 17 in a clinical trial, the company announced Tuesday.
Moderna’s COVID-19 vaccine was 100% effective in adolescents aged 12 to 17 in a clinical trial, the company announced Tuesday.